Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7MXF | P61769 | CD1c with antigen analogue 2 | |
| 7MZK | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
| 7MZK | 7MZK | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
| 7MZM | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
| 7MZM | 7MZM | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
| 7N1I | A0A0C4MX98 | CryoEM structure of Venezuelan equine encephalitis virus VLP | |
| 7N5H | P0DTC2 | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7N5H | 7N5H | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7N6U | Q75760 | Structure of uncleaved HIV-1 JR-FL Env glycoprotein trimer in state U1 bound to small Molecule HIV-1 Entry Inhibitor BMS-378806 | |
| 7OUL | P31224 | BDM88832 inhibitor bound to the transmembrane domain of AcrB-R971A | |
| 7OUL | 7OUL | BDM88832 inhibitor bound to the transmembrane domain of AcrB-R971A | |
| 7P1D | Q0CMX0 | Structure of KDNase from Aspergillus Terrerus in complex with 2-keto-3-deoxynononic acid | |
| 7P1P | P22303 | Crystal structure of human acetylcholinesterase in complex with (E)-3-hydroxy-6-(3-(4-(4-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)propyl)picolinaldehyde oxime | |
| 7P9V | P08195 | Cryo EM structure of System XC- | |
| 7P9V | Q9UPY5 | Cryo EM structure of System XC- | |
| 7PEE | P09758 | Crystal structure of extracellular part of human Trop2 | |
| 7R84 | Q3UHD1 | Structure of mouse BAI1 (ADGRB1) TSR3 domain in P21 space group | |
| 7SOD | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
| 7SOD | 7SOD | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
| 7SY0 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
| 7SY0 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
| 7V7E | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1 | |
| 7V83 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V83 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V83 | 7V83 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V83 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V83 | 7V83 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V84 | P0DTC2 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V84 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V84 | 7V84 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V84 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V84 | 7V84 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V85 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V85 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V85 | 7V85 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V85 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V85 | 7V85 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V86 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
| 7V86 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
| 7V86 | 7V86 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
| 7V86 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
| 7V86 | 7V86 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
| 7V87 | P0DTC2 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V87 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V87 | 7V87 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V87 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V87 | 7V87 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V88 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V88 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V88 | 7V88 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form |
